Prevention Tips for Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that originates in the bone marrow, disrupting the normal production of blood cells. There is no guaranteed way to prevent AML, but understanding which risk factors can be changed helps put realistic prevention steps in perspective.
Key Takeaways
- AML cannot be reliably prevented; most people who develop it have no avoidable cause, and most known risk factors cannot be changed.
- Smoking and long-term exposure to benzene are the only risk factors for AML that are clearly modifiable — avoiding both is the single most evidence-based step available.
- General healthy-weight, diet, and alcohol-moderation habits support overall health but have not been shown to specifically lower AML risk.
- People whose medical history includes myelodysplastic syndrome, another blood disorder, or prior chemotherapy or radiation are better served by regular medical monitoring than by lifestyle prevention alone.
- There is no recommended screening test for AML in people at average risk; routine blood work helps catch changes early in those already under medical follow-up.
Can Acute Myeloid Leukemia (AML) Be Prevented?
Acute myeloid leukemia (AML) develops in the myeloid line of blood cells within the bone marrow, where abnormal cells multiply quickly and crowd out healthy blood cells. Unlike cancers that have a single, clearly avoidable cause, AML usually results from a combination of genetic change, environmental exposure, and personal medical history, so complete prevention is not possible for most people.
The National Cancer Institute lists smoking as one of the few AML risk factors a person can change; other established risk factors — including age, sex, genetic makeup, and past medical treatment — cannot be modified. Reducing exposure to known contributors such as tobacco smoke and benzene is a reasonable, evidence-based step, but it does not guarantee that AML will not develop, since many cases occur with no identifiable avoidable cause.
For people already at higher risk — such as those with a pre-existing blood disorder or a history of chemotherapy or radiation therapy — prevention efforts shift away from lifestyle change and toward closer medical monitoring aimed at catching problems early rather than avoiding them altogether.
Key Risk Factors That Influence AML Development
Sorting out AML risk factors and prevention starts with separating what can be changed from what cannot. Non-modifiable factors include older age, being male, having an inherited condition such as Down syndrome or Fanconi anemia, and a medical history that includes myelodysplastic syndrome or another blood disorder. Prior treatment with chemotherapy or radiation therapy for another condition also raises risk, but it reflects medical history rather than a choice that can be undone.
Among the factors that can be modified, smoking is the most consistently documented. Tobacco smoke carries benzene and other compounds that can damage the DNA of developing blood cells, so quitting is the step most clearly tied to lower AML risk. Long-term occupational or environmental exposure to benzene — found in gasoline, cigarette smoke, and some industrial solvents — and exposure to high-dose ionizing radiation are the other contributors directly linked to AML; both can often be reduced, even if not eliminated entirely, depending on a person’s work and environment.
| Risk Factor | Can It Be Changed? |
|---|---|
| Smoking | Yes |
| Occupational or environmental benzene exposure | Partly — exposure can be reduced |
| High-dose ionizing radiation exposure | Partly — exposure can be reduced |
| Older age | No |
| Male sex | No |
| Personal history of a blood disorder (e.g., myelodysplastic syndrome) | No |
| Certain inherited conditions (e.g., Down syndrome, Fanconi anemia) | No |
| Prior chemotherapy or radiation therapy | No — reflects past treatment |
Source: NCI risk factor list for AML.
A more detailed look at how each of these factors contributes to AML risk is covered on this site’s dedicated causes and risk factors page; the summary above focuses only on which of them can realistically be addressed.
Prevention Tips for Acute Myeloid Leukemia: Lifestyle and Environmental Steps
Because only a few AML risk factors are modifiable, prevention efforts are necessarily narrow. The two steps most directly tied to AML risk are not smoking and limiting exposure to benzene.
Avoiding tobacco in every form removes a major source of benzene and other DNA-damaging compounds from the body. For people who currently smoke, structured cessation support — counseling, nicotine replacement, or prescription medication — improves the odds of quitting successfully, and avoiding secondhand smoke deserves the same consideration.
People who work in industries where benzene is more common, including petroleum refining, rubber manufacturing, and some chemical processing, can lower exposure by following workplace safety practices and using protective equipment consistently. Limiting non-essential radiation exposure, and asking a healthcare provider whether a particular imaging test is necessary, is a reasonable precaution for anyone concerned about cumulative radiation dose.
Beyond these two exposures, no diet, supplement, weight-management program, or alcohol-limiting strategy has been shown to specifically lower AML risk. General health habits — eating a varied diet, staying physically active, and drinking alcohol only in moderation — support overall well-being and are worth adopting for that reason, but they should not be presented as proven ways to prevent this particular cancer. Framing prevention this way keeps expectations realistic: someone who avoids every known exposure can still develop AML, and someone with several risk factors may never develop it.
Medical Monitoring and Early Intervention to Lower AML Risk
For people with a known elevated risk — such as a diagnosis of myelodysplastic syndrome, a myeloproliferative neoplasm, or aplastic anemia, or a history of chemotherapy or radiation therapy for another cancer — medical monitoring plays a larger role in managing AML risk than lifestyle change does. These are considered pre-leukemic conditions that can, in some cases, progress to AML over time, so working with a hematologist to set a monitoring plan is the recommended approach rather than relying on general prevention advice.
Routine complete blood count testing is a simple, low-burden way to flag unexpected changes in red cell, white cell, or platelet counts before symptoms appear. A CBC alone cannot diagnose AML, but an unexpected result can prompt further evaluation, such as a bone marrow biopsy, at an earlier and potentially more treatable stage.
Anyone who has previously received chemotherapy or radiation therapy for another cancer should make sure every treating physician is aware of that history so it can be factored into long-term follow-up care. Genetic counseling may also help people with a strong family history of blood cancers or a known inherited condition linked to AML; it cannot prevent the disease, but it can clarify personal risk and help guide how often monitoring is needed.
Frequently Asked Questions
Is there a diet or supplement proven to prevent AML?
No diet or supplement has been shown to prevent AML. Eating a varied diet with plenty of vegetables, fruits, and whole grains supports general health, but supplements should not replace medical care — anyone considering one, especially during treatment or with an existing blood disorder, should check with a healthcare provider first.
Does a family history of leukemia significantly increase my AML risk?
A family history involving an inherited condition linked to AML, such as Fanconi anemia or Down syndrome, can raise risk, but most people diagnosed with AML have no identifiable family or genetic link. Anyone concerned about a strong family history of blood cancers can ask a doctor whether genetic counseling is appropriate.
Should people with myelodysplastic syndromes take specific steps to prevent AML progression?
People with myelodysplastic syndromes face a real risk of progression to AML and should stay under active hematologic care, including regular blood counts and, when recommended, bone marrow evaluations. Avoiding smoking and unnecessary chemical exposure remains reasonable general advice, though it has not been shown to stop MDS from progressing.
Sources
